Crossmark

Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy

Published Online: 2026-02-23

Authors

Deng, Yaxing

Wang, Xin

Zeng, Mei

Wang, Chenglin
License Information

Text and Data Mining valid from 2026-02-23

Accepted Manuscript valid from 2026-02-23
More Information

Article History

Received: 14 June 2025

Accepted: 10 February 2026

First Online: 23 February 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current